The "Biopharmaceutical Contract Development and Manufacturing Organization Market 2026-2033" has been added to ResearchAndMarkets.com's offering. The global biopharmaceutical contract development and ...

The trends and disruptions impacting customers in the biopharmaceutical industry are centered on increasing demands for higher product quality, faster therapy development, stronger regulatory ...

The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

Today’s most common biopharmaceutical manufacturing systems require the handling, transferring, processing, and purification of large-molecule drugs produced in living cells—cultured animal cells, ...

GEN: Your company maintains that the supply chain of single-use assemblies is the biggest bottleneck in biopharmaceutical manufacturing. Can you talk about why that is the case and how you address ...

Process analytical technology (PAT) describes the FDA-endorsed framework for measuring and controlling pharmaceutical manufacturing processes through real-time data collection and analysis. The FDA's ...

Chitose Laboratory Corp., (CHITOSE), a leading company of the bioeconomy and provider of advanced cell line development services, and FUJIFILM Biosciences Inc., a global leader in the innovation and ...

With the increasing amount of available data, AI and machine learning have emerged as crucial tools for biopharmaceutical companies looking to remain competitive in the market. These tools are helping ...

TOKYO--(BUSINESS WIRE)--Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of contract process ...

DELRAY BEACH, Fla., July 28, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Biopharmaceutical Process Analytical Technology Market is projected to reach USD 4.32 billion by 2031 from USD ...